Viewing Study NCT02876055



Ignite Creation Date: 2024-05-06 @ 9:00 AM
Last Modification Date: 2024-10-26 @ 12:08 PM
Study NCT ID: NCT02876055
Status: COMPLETED
Last Update Posted: 2019-04-16
First Post: 2016-08-18

Brief Title: Analgesic Efficacy of Interscalene Nerve Block Versus Local Infiltration Analgesia Following Total Shoulder Arthroplasty
Sponsor: Mayo Clinic
Organization: Mayo Clinic

Study Overview

Official Title: Prospective Randomized Controlled Trial Comparing Analgesic Efficacy of Single Injection vs Continuous Interscalene Blockade vs Local Infiltration Analgesia for Patients Undergoing Primary Total Shoulder Arthroplasty
Status: COMPLETED
Status Verified Date: 2019-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Total shoulder arthroplasty TSA is considered to be a major surgical procedure resulting in severe postoperative pain especially in the first 48 hours after surgery The use of interscalene brachial plexus nerve block remains the cornerstone for analgesia following shoulder surgery however with the advent of local infiltration analgesia LIA there has been increasing interest in its use for total joint arthroplasty

Since the benefits of local infiltration analgesia within a comprehensive multi-modal analgesia clinical pathway have yet to be established for total shoulder arthroplasty the Investigators plan to assess and compare analgesia outcomes between three intervention groups single shot interscalene brachial plexus block SISB continuous interscalene brachial plexus block CISB and local infiltration analgesia LIA
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None